The world’s first notably effective malaria vaccine is set to save thousands of lives throughout Ghana, Kenya, and Malawi starting in 2018.
The World Health Organization Regional Office for Africa is introducing the RTS,S; the first malaria vaccine to have successfully completed a Phase III clinical trial – which was completed in 2014 – to Africa.
The RTS,S’s pilot program will be conducted on children ages 5 to 17 months old in hopes that it will drastically reduce infection throughout the poorest regions of Africa. The study will assess the efficiency of the vaccine by delivering four injections of RTS,S to infants in high-risk areas for the disease.
“The prospect of a malaria vaccine is great news. Information gathered in the pilot will help us make decisions on the wider use of this vaccine”, said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Combined with existing malaria interventions, such a vaccine would have the potential to save tens of thousands of lives in Africa.”
Give Your Friends A Daily Dose Of Good News: Click To Share – OR,
Reprint (Photo by Dr PS Sahana Kadamtala Howrah, CC)